What's Happening

Indicated for the treatment of erectile dysfunction

A biosimilar to Stelara; indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, moderately to severely active Crohn’s disease, and moderately to severely active ulcerative colitis

A new chewable tablet indicated for the treatment of erectile dysfunction, and the signs and symptoms of benign prostatic hyperplasia

Indicated for the treatment of HIV-1 infection, in combination with other antiretroviral agents

Indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure

Indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression

A biosimilar of Stelara^®, this drug is indicated for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis

A long-acting, atypical antipsychotic indicated for the treatment of schizophrenia

A first-in-class biologic indicated for the treatment of pulmonary arterial hypertension to increase exercise capacity and reduce the risk of clinical worsening events

Indicated for the treatment of pulmonary arterial hypertension, both in patients who are treatment naïve or who are already on an ERA, PDE5 inhibitor or both

Indicated for the treatment of hypertension in combination with other antihypertensive drugs to lower blood pressure

A biosimilar to Humira, this drug is indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, ankylosing spondylitis, and plaque psoriasis

Indicated for the treatment of HIV-1 infection

Indicated for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate

Indicated for the treatment of moderate to severe dementia of the Alzheimer’s type in patients stabilized on 10 mg of donepezil hydrochloride once daily